AzTrials
AzTrials

Local AnesthesiaNCT06519838

Effect of Pre-Warming of Local Anesthesia in Reducing Pain Perception During Injection in Children

A study testing Local anesthesia solution at room temperature, Local anesthesia solution pre-warmed to 37°C and Local anesthesia solution pre-warmed to 40°C in people with Local Anesthesia and Dental Anesthesia, run by Andrew Emad at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the current study was to evaluate the pain perception upon injection of pre-warmed dental anesthetic solution (at 370C and 400C) versus that at room temperature (Average 23 degrees) during Maxillary Infiltration and Mandibular Inferior Alveolar Nerve Block techniques in children Read more about this study

Who is it for?
Ages 5 to 7 years
Conditions the study is for
Local Anesthesia, Dental Anesthesia
What is being tested?
Local anesthesia solution at room temperature, Local anesthesia solution pre-warmed to 37°C and Local anesthesia solution pre-warmed to 40°C
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteEgypt
Study dates
1 Jan 2024to 10 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 7 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Healthy patients with ASA 1 or 2 Classification.
  • Patients with Frankl Behavior Classification 3-4.
  • Patients having at least one carious primary molar that requires dental treatment under the effect of local anesthesia.
  • Parents' willingness to participate through informed written consent.

Who cannot join

  • Patients with previous negative dental experience.
  • Patients complaining of cellulitis or infection spreading in the fascial spaces.
  • Patients who have received analgesics within the previous 12 hours before receiving the required dental treatment.
  • Patients with any Intellectual Impairment.
  • Patients with a history of allergy from any of the components of the dental anesthetic carpule.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Alexandria University

    Alexandria

Other trials in Egypt

About this study

Official title: Effect of Pre-Warming of Local Anesthesia in Reducing Pain Perception During Injection in Children: A Randomized Controlled Clinical Trial

The aim of the current study was to evaluate the pain perception upon injection of pre-warmed dental anesthetic solution (at 370C and 400C) versus that at room temperature (Average 23 degrees) during Maxillary Infiltration and Mandibular Inferior Alveolar Nerve Block techniques in children

Being tested
Local anesthesia solution at room temperature, Local anesthesia solution pre-warmed to 37°C, Local anesthesia solution pre-warmed to 40°C, Maxillary infiltration technique, Inferior alveolar nerve block technique

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Local anesthesia solution at room temperatureOther

    The local anesthesia cartridge is used at room temperature (average of 21 °C)

  • Local anesthesia solution pre-warmed to 37°COther

    About 150 ml of water at 21°C is added to the heating compartment of the heating device. The Local anesthesia cartridge is placed at the bottom of the heating compartment. The device is plugged in and the control gauge is set at the "Express milk warming setting for contents up to 180ml/6oz" mark. The contents would reach 37°C at 120 seconds.

  • Local anesthesia solution pre-warmed to 40°COther

    About 150 ml of water at 21°C is added to the heating compartment of the heating device. The Local anesthesia cartridge is placed at the bottom of the heating compartment. The device is plugged in and the control gauge is set at the "Express milk warming setting for contents up to 180ml/6oz" mark. The contents would reach 40°C at 130 seconds.

  • Maxillary infiltration techniqueOther

    A 30 gauge short needle is oriented so that the bevel is facing the bone. The syringe is held parallel to the long axis of the tooth and the needle is inserted into the height of the mucobuccal fold over the offending tooth. The needle is advanced to a depth of 1 millimeter into the tissues. Aspiration is done, and once it is negative then 0.6 ml (nearly one third of the cartridge) of the anesthetic solution is injected slowly without permitting the tissues to balloon.

  • Inferior alveolar nerve block techniqueOther

    While the mouth is opened as wide as possible, the index finger palpates the external oblique ridge reaching the Coronoid notch. A 27-gauge long dental needle will be used for injection. The needle will be directed between the two primary molars on the opposing side of the arch, penetrating the tissues at the point halfway between coronoid notch and the pterygomandibular raphe at the occlusal plane level or slightly lower.The needle is withdrawn 2mm to aspirate. Once negative aspiration is checked, the remainder of the solution is deposited slowly. Approximately 1.0 mL of LA will be delivered near the inferior alveolar nerve. The average depth of insertion is about 15mm, which is nearly two-thirds the needle length.

Study groups in NCT06519838
Study groupRoleWhat they receive
Maxillary infiltration at room temperatureActive comparatorNot described
Receives: Other: Local anesthesia solution at room temperature; Other: Maxillary infiltration technique
Inferior alveolar nerve block at room temperatureActive comparatorNot described
Receives: Other: Local anesthesia solution at room temperature; Other: Inferior alveolar nerve block technique
Maxillary infiltration pre-warmed to 37°CExperimentalNot described
Receives: Other: Local anesthesia solution pre-warmed to 37°C; Other: Maxillary infiltration technique
Inferior alveolar nerve block pre-warmed to 37°CExperimentalNot described
Receives: Other: Local anesthesia solution pre-warmed to 37°C; Other: Inferior alveolar nerve block technique
Maxillary infiltration pre-warmed to 40°CExperimentalNot described
Receives: Other: Local anesthesia solution pre-warmed to 40°C; Other: Maxillary infiltration technique
Inferior alveolar nerve block pre-warmed to 40°CExperimentalNot described
Receives: Other: Local anesthesia solution pre-warmed to 40°C; Other: Inferior alveolar nerve block technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart rate (HR) monitoring

    A pulse oximeter will be used to record and measure the patient's heart rate. A baseline reading will be obtained before the LA administration and another reading will be obtained directly after the injection is carried out. Heart rate ranging between 70-100 is considered normal.

    Measured: during local anesthesia administration

  2. Pain during injection using Sound, Eye, Motor (SEM) Scale

    Sound, Eye, Motor (SEM) Scale was used as an objective mean to assess pain during local anesthesia administration. It comprises the following parameters:

    • Sound
    • Eye
    • Bodily movements The slightest changes in the sound, eye movement and bodily movement of the patient will be categorized as one of the following levels; comfortable, mild, moderate, and severe discomfort and hence given a grade of 1, 2, 3 or 4 respectively. The final SEM score will be calculated by adding the grades of the three parameters.

    Measured: during local anesthesia administration

  3. Pain during injection using Face scale

    To assess pain subjectively during local anesthesia administration, a modified face scale. It consists of three schematic faces with different facial expressions for happy and sad faces representing:

    1. Satisfaction
    2. Indifference
    3. Dissatisfaction Each patient was trained on using the scale by modelling and then requesting from every patient to think of the last time she/he went through a painful experience and to choose the facial expression that best relates his/her current experience of discomfort to the previous one

    Measured: during local anesthesia administration

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2024
  2. Study start1 Jan 2024
  3. Primary completion10 Jun 2024
  4. Study completion10 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06519838
Sponsor's protocol ID
1/2023
Status last verified
Jul 2024
First submitted
14 Jul 2024
Last updated
25 Jul 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Local anesthesia solution at room temperature, Local anesthesia solution pre-warmed to 37°C and Local anesthesia solution pre-warmed to 40°C in people with Local Anesthesia and Dental Anesthesia, run by Andrew Emad at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart rate (HR) monitoring (time frame: during local anesthesia administration). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in